BRIAN A. MARKISON

Insider Reports History

Location: Bristol, TN
Signature: /s/ Eric M. Green, attorney-in-fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Company	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Lantheus Holdings, Inc.	CEO, Director	Common Stock	232,420	$22,047,361	$94.86	05 Mar 2025	Direct
RVL Pharmaceuticals plc	Chief Executive Officer, Director	Ordinary Shares	2,976,020	$92,852	$0.0312	08 Aug 2022	Direct
Osmotica Pharmaceuticals plc	Chief Executive Officer, Director	Share Option (Right to Buy)	615,000			04 Nov 2021	Direct
Lantheus Holdings, Inc.	CEO, Director	Stock Option (right to buy)	41,347			05 Mar 2025	Direct

Symbol	Company	Period	Transactions	Value $	Form Type	Role	Filing Time
LNTH	Lantheus Holdings, Inc.	05 Mar 2025	2	$0	4	CEO, Director	07 Mar 2025, 17:43
LNTH	Lantheus Holdings, Inc.	03 Mar 2025	1	-$819,306	4	CEO, Director	05 Mar 2025, 17:12
LNTH	Lantheus Holdings, Inc.	19 Dec 2024	5	-$1,107,920	4	CEO, Director	23 Dec 2024, 19:33
LNTH	Lantheus Holdings, Inc.	01 Mar 2024	1	$0	4	CEO, Director	05 Mar 2024, 20:09
LNTH	Lantheus Holdings, Inc.	11 May 2023	2	$0	4	Director	15 May 2023, 18:44
LNTH	Lantheus Holdings, Inc.	27 Mar 2023	1	-$1,078,218	4	Director	29 Mar 2023, 17:51
LNTH	Lantheus Holdings, Inc.	08 Sep 2022	9	-$3,072,460	4	Director	12 Sep 2022, 16:30
LNTH	Lantheus Holdings, Inc.	06 Sep 2022	3	-$99,413	4	Director	08 Sep 2022, 16:30
/report/000110465922088034-markison-brian-a-2022-08-08	RVL Pharmaceuticals plc	08 Aug 2022	1	+$1,317,500	4	Chief Executive Officer, Director	09 Aug 2022, 17:22
LNTH	Lantheus Holdings, Inc.	06 May 2022	1	$0	4/A	Director	12 May 2022, 17:48
/report/000110465921135636-markison-brian-a-2021-11-04	Osmotica Pharmaceuticals plc	04 Nov 2021	1	$0	4	Chief Executive Officer, Director	08 Nov 2021, 15:05
LNTH	Lantheus Holdings, Inc.	10 May 2021	1	$0	4	Director	12 May 2021, 16:30